A panel from the US Food and Drug Administration (FDA) confirmed on Wednesday the effectiveness and safety data of the Johnson & Johnson (J&J) covid-19 vaccine , which requires a single injection, with what your emergency authorization to incorporate it into the vaccination campaign could be imminent.
Graph on the distribution of covid-19 vaccines. The world is divided by the Covid vaccine: the fight for ‘liquid gold’ and dominate the supply.
The FDA’s vaccine advisory committee will now be the one that, based on this report and the data provided by Johnson & Johnson, will decide this Friday if the vaccine is incorporated into the other two already authorized: that of Pfizer / BioNTech and the by Moderna.
Earlier this month, Johnson & Johnson said that clinical trial data indicates that its Covid-19 vaccine has an overall effectiveness in immunizing against the disease of 66% ; 72% in tests carried out in the United States; 66% in Latin America and 64% in South Africa, where a more resistant variant has spread.
This vaccine can speed up the vaccination campaign
Trials have shown that the vaccine prevents 86% of serious cases in the United States and 82% in Latin America, which in practice would mean that it is highly effective in preventing hospitalizations and deaths from the SARS-CoV-2 coronavirus.
The fact that this vaccine is intended to be administered in a single injection, unlike those of Pfizer and Moderna, which require two appointments, makes it one of the most anticipated , as it would speed up the vaccination campaign.
Vaccine effectiveness against new coronavirus variants. New variants threaten the effectiveness of vaccines: Which ones are most effective for each strain?
The FDA considers it proven that the new vaccine is highly effective in preventing serious cases and deaths from covid-19 and should contain the spread of the disease, which has claimed more than half a million lives in the United States in just over one year.
Johnson & Johnson’s vaccine could gain emergency approval this Friday, with the decision announced on Saturday , and immediately begin distribution across the country to the hundreds of vaccination centers that have already begun inoculating the elderly and other populations. risk groups.
The new vaccine can be stored in ordinary refrigerators for at least three months , making it logistically easier to handle than those from Pfizer and Moderna, which require more extreme subzero temperatures, but have a percentage of efficacy older, up to 95%.